Exercise and Nutrition Interventions for Platinum Chemotherapy-induced Neuropathy R21

Sponsor
University of Maryland, Baltimore
Status
Recruiting
ClinicalTrials.gov ID
For more information, see ClinicalTrials.gov NCT05452902
Chemotherapy-induced peripheral neuropathy (CIPN) is a highly prevalent and severe side-effect of platinum-based chemotherapy, often used to treat gastrointestinal cancers. Unfortunately there are very limited treatments for CIPN. This is a phase II randomized controlled trial to test the preliminary efficacy of exercise vs. nutrition education on CIPN, to systematically investigate the potential roles of inflammation and interoception, and to obtain data with a more accurate effect size to inform a future study.
Intervention
Nutrition Education, EXCAP Exercise
Condition
Chemotherapy-induced Peripheral Neuropathy
Investigators
Ian Kleckner, PhD, MPH

See list of participating sites